Omnipod 5 DEXG7G6 pods (GEN 5) 5S
Ended Awarded Last action
- Contract number
- SPE2DR26FNQ2A
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,096
Award facts
- Contract value 100% obligated
- $18,095.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order contract valued at $18,095.76 to AmerisourceBergen Drug Corp for the supply of OmniPod 5 Dexcom G7 Generation 5 insulin infusion pods. This firm fixed-price, non-set-aside delivery order, issued on December 17, 2025, with completion targeted for December 18, 2025, represents a critical medical supply for military and veteran healthcare systems. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and is a registered federal vendor specializing in medical procurement for defense healthcare needs.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The company's demonstrated capability in delivering diabetes management solutions and specialized medical devices through multiple competitive awards positions it as a key vendor within the Defense Health Agency's medical supply chain for innovative endocrine care solutions.
Quick answers
Who was awarded contract SPE2DR26FNQ2A?
SPE2DR26FNQ2A was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 17, 2025.
How much is contract SPE2DR26FNQ2A worth?
The government has obligated $18,096 on SPE2DR26FNQ2A.
Is contract SPE2DR26FNQ2A an order under another contract?
Yes. SPE2DR26FNQ2A is a delivery order under SPE2DR25D1021, an indefinite delivery contract.
Was contract SPE2DR26FNQ2A competed?
The extent of competition for SPE2DR26FNQ2A was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award